Table 2.
Immunoglobulin | Control | ETEC challenge | Levels of anti-ETEC IgY(mg/mL) | Non-specific IgY | SEM | P value | ||
---|---|---|---|---|---|---|---|---|
32 | 16 | 8 | ||||||
IgG, μg/mL | 312.29b | 401.28a | 333.56b | 350.20b | 340.34b | 394.71a | 9.46 | < 0.01 |
IgM, μg/mL | 48.50 | 52.27 | 48.36 | 50.43 | 47.10 | 47.00 | 3.27 | 0.86 |
IgA, ng/mL | 460.33c | 543.04a | 485.42bc | 463.43c | 510.40ab | 539.71a | 9.47 | < 0.01 |
sIgA, μg/mL | 12.22c | 13.22bc | 14.54ab | 15.35a | 13.90b | 13.64bc | 0.31 | < 0.01 |
a-cValues with different superscripts within a row differ (P < 0.05), n=6. Mice in control group were not challenged with ETEC K88. Mice in ETEC group were challenged with ETEC K88 and treated with PBS. Mice in IgY groups were challenged with ETEC K88 and treated with 250 μL of high-, medium- or low-doses of anti-ETEC IgY or 250 μL of non-specific IgY.